<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://www.belgiumentertainmentdispatch.com/article/909286944-man-science-appoints-prof-jean-pierre-van-buyten-as-chief-medical-officer</loc>
      <news:news>
        <news:publication>
          <news:name>Belgium Entertainment Dispatch</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-07T08:00:00+00:00</news:publication_date>
        <news:title>Man &amp; Science Appoints Prof. Jean-Pierre Van Buyten as Chief Medical Officer</news:title>
      </news:news>
    </url>
    <url>
      <loc>https://www.belgiumentertainmentdispatch.com/article/910795980-bioxodes-presents-positive-final-phase-2a-intracerebral-hemorrhage-results-at-esoc-affirming-breakthrough-potential-of-biox-101</loc>
      <news:news>
        <news:publication>
          <news:name>Belgium Entertainment Dispatch</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-06T12:30:00+00:00</news:publication_date>
        <news:title>Bioxodes presents positive final Phase 2a intracerebral hemorrhage results at ESOC affirming breakthrough potential of BIOX-101</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/11568637-8587-499f-8472-d6009ae7d0ba/small/bioxodes-logo-fond-transparent-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.belgiumentertainmentdispatch.com/article/910587060-neuvasq-presents-data-showcasing-promising-novel-multispecific-gpr124-targeting-antibodies-for-blood-retina-barrier-restoration-at-arvo-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Belgium Entertainment Dispatch</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T19:15:00+00:00</news:publication_date>
        <news:title>Neuvasq Presents Data Showcasing Promising Novel Multispecific Gpr124-Targeting Antibodies for Blood Retina Barrier Restoration at ARVO 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/758fbb1f-ac3c-4f37-ba02-64c0f59beff0/small/neuvasq-logo-png-png.png</image:loc>
        </image:image>
    </url>
</urlset>
